Literature DB >> 15213581

Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.

Howard Abikoff1, Lily Hechtman, Rachel G Klein, Gabrielle Weiss, Karen Fleiss, Joy Etcovitch, Lorne Cousins, Brian Greenfield, Diane Martin, Simcha Pollack.   

Abstract

OBJECTIVE: To test the hypotheses that in children with attention-deficit/hyperactivity disorder (ADHD) (1) symptoms of ADHD, oppositional defiant disorder, and overall functioning are significantly improved by methylphenidate combined with intensive multimodal psychosocial treatment compared with methylphenidate alone and with methylphenidate plus attention control and (2) more children receiving combined treatment can be taken off methylphenidate.
METHOD: One hundred three children with ADHD (ages 7-9), free of conduct and learning disorders, who responded to short-term methylphenidate were randomized for 2 years to (1) methylphenidate alone; (2) methylphenidate plus psychosocial treatment that included parent training and counseling, social skills training, psychotherapy, and academic assistance, or (3) methylphenidate plus attention psychosocial control treatment. Assessments included parent, teacher, and psychiatrist ratings, and observations in academic and gym classes.
RESULTS: Combination treatment did not lead to superior functioning and did not facilitate methylphenidate discontinuation. Significant improvement occurred across all treatments and continued over 2 years.
CONCLUSIONS: In stimulant-responsive children with ADHD, there is no support for adding ambitious long-term psychosocial intervention to improve ADHD and oppositional defiant disorder symptoms. Significant benefits from methylphenidate were stable over 2 years. Copyright 2004 American Academy of Child and Adolescent Psychiatry

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213581     DOI: 10.1097/01.chi.0000128791.10014.ac

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  59 in total

1.  Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancer.

Authors:  Kelli L Netson; Heather M Conklin; Jason M Ashford; Lisa S Kahalley; Shengie Wu; Xiaoping Xiong
Journal:  J Pediatr Psychol       Date:  2010-11-19

2.  Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.

Authors:  Catherine A Fullerton; Arnold M Epstein; Richard G Frank; Sharon-Lise T Normand; Christina X Fu; Thomas G McGuire
Journal:  Psychiatr Serv       Date:  2012-02-01       Impact factor: 3.084

3.  Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD?

Authors:  Saskia van der Oord; Pier J M Prins; Jaap Oosterlaan; Paul M G Emmelkamp
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-09-13       Impact factor: 4.785

4.  Deciding on stimulant use for childhood ADHD: maintaining focus on the key questions.

Authors:  John D McLennan
Journal:  Can Fam Physician       Date:  2006-08       Impact factor: 3.275

5.  Influence of Methylphenidate on Long-Term Neuropsychological and Everyday Executive Functioning After Traumatic Brain Injury in Children with Secondary Attention Problems.

Authors:  Elizabeth LeBlond; Julia Smith-Paine; Jacqlyn J Riemersma; Paul S Horn; Shari L Wade; Brad G Kurowski
Journal:  J Int Neuropsychol Soc       Date:  2019-08       Impact factor: 2.892

Review 6.  A Review of the Clinical Utility of Systematic Behavioral Observations in Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Franziska Minder; Agnieszka Zuberer; Daniel Brandeis; Renate Drechsler
Journal:  Child Psychiatry Hum Dev       Date:  2018-08

Review 7.  Multimodal treatments for childhood attention-deficit/hyperactivity disorder: interpreting outcomes in the context of study designs.

Authors:  Betsy Hoza; Nina M Kaiser; Elizabeth Hurt
Journal:  Clin Child Fam Psychol Rev       Date:  2007-12

Review 8.  Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research.

Authors:  Brooke S G Molina; William E Pelham
Journal:  Annu Rev Clin Psychol       Date:  2014-01-15       Impact factor: 18.561

Review 9.  ADHD in children and adolescents.

Authors:  Daphne Keen; Irene Hadijikoumi
Journal:  BMJ Clin Evid       Date:  2008-10-02

10.  Packages of care for attention-deficit hyperactivity disorder in low- and middle-income countries.

Authors:  Alan J Flisher; Katherine Sorsdahl; Sean Hatherill; Sonia Chehil
Journal:  PLoS Med       Date:  2010-02-23       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.